Physician profile
John Merey
NPI 1942228507
$1,924.49
in general payments reported to CMS, 2019-2025
13 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $464 · 2020: $88.53 · 2021: $821 · 2022: $229 · 2023: $121 · 2024: $201.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $322.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $321.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Horizon Therapeutics Plc | $360.53 | 2021-2022 | |
| Aerie Pharmaceuticals, INC. | $345.34 | 2019-2021 | |
| Allergan, INC. | $212.18 | 2019-2020 | |
| Sun Pharmaceutical Industries INC. | $125.01 | 2021 | |
| Abbvie INC. | $125.00 | 2024 | |
| Ocular Therapeutix, INC. | $120.71 | 2023 | Dextenza |
| Kala Pharmaceuticals, INC. | $118.11 | 2021 | |
| Mallinckrodt Hospital Products INC. | $107.29 | 2022 | |
| Spark Therapeutics, INC. | $105.68 | 2019 | |
| Novartis Pharmaceuticals Corporation | $103.52 | 2019 | |
| Johnson & Johnson Surgical Vision, INC. | $98.77 | 2021 | |
| Incyte Corporation | $76.10 | 2024 | Opzelura |
| Boston Scientific Corporation | $26.25 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Merey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.